MedTrace Logo

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II

NCT06576427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2026-04-06

No results posted yet for this study

Summary

This study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism.

Conditions

Interventions

DEVICE

Vertex Pulmonary Embolectomy System

Use of Vertex Pulmonary Embolectomy System to treat pulmonary embolism.

Sponsors & Collaborators

  • Jupiter Endovascular

    lead INDUSTRY

Principal Investigators

  • Aadi Chachad · Sponsor GmbH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-15
Primary Completion
2026-02-04
Completion
2026-03-03
FDA Device
Yes

Countries

  • United States
  • Austria
  • Poland
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06576427 on ClinicalTrials.gov